These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


530 related items for PubMed ID: 34373422

  • 61. Dysautonomia associated with immune checkpoint inhibitors.
    Tezuka T, Okuzumi S, Nakashima C, Ide T, Imai S, Mitsuboshi S, Kuwahara Y, Takizawa T, Seki M, Minematsu N, Aragane N, Nakahara J, Hori S, Nakane S, Suzuki S.
    J Neurol; 2023 Jul; 270(7):3413-3423. PubMed ID: 36939931
    [Abstract] [Full Text] [Related]

  • 62. Adrenal Insufficiency and Thyrotoxicosis Following Combined Immune Checkpoint Inhibitor Use: A Case Report and Literature Review.
    Fukushima K, Kitayama S, Sazuka M, Kodera R, Oba K, Toyoshima K, Chiba Y, Yamamoto H, Araki A, Tamura Y.
    Cureus; 2024 May; 16(5):e60850. PubMed ID: 38910605
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70. [A case of meningoencephalitis and polyradiculoneuropathy induced by combination therapy with ipilimumab and nivolumab].
    Ohno N, Sugimoto T, Giga M, Naito H, Kono T, Nomura E.
    Rinsho Shinkeigaku; 2021 Oct 28; 61(10):658-662. PubMed ID: 34565749
    [Abstract] [Full Text] [Related]

  • 71. Incidence of diabetes mellitus in patients treated with immune checkpoint inhibitors (ICI) therapy - A comprehensive cancer center experience.
    Zhang Z, Sharma R, Hamad L, Riebandt G, Attwood K.
    Diabetes Res Clin Pract; 2023 Aug 28; 202():110776. PubMed ID: 37311494
    [Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73. Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab.
    Cappelli LC, Gutierrez AK, Baer AN, Albayda J, Manno RL, Haque U, Lipson EJ, Bleich KB, Shah AA, Naidoo J, Brahmer JR, Le D, Bingham CO.
    Ann Rheum Dis; 2017 Jan 28; 76(1):43-50. PubMed ID: 27307501
    [Abstract] [Full Text] [Related]

  • 74. [Immune checkpoint inhibitors and endocrinological side effects].
    Jørgensen LB, Bastholt L, Yderstræde K.
    Ugeskr Laeger; 2017 Dec 04; 179(49):. PubMed ID: 29212592
    [Abstract] [Full Text] [Related]

  • 75. [INTERSTITIAL NEPHRITIS CAUSED BY IPILIMUMAB AND NIVOLUMAB COMBINATION THERAPY FOR ADVANCED RENAL CELL CARCINOMA: A CASE REPORT].
    Ishii M, Takezawa K, Imamura R, Fukuhara S, Fujita K, Uemura M, Kiuchi H, Nonomura N.
    Nihon Hinyokika Gakkai Zasshi; 2021 Dec 04; 112(2):109-112. PubMed ID: 35444079
    [Abstract] [Full Text] [Related]

  • 76.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Acute pancreatitis without abdominal pain induced by administration of nivolumab and ipilimumab.
    Yamamoto K, Oka K, Son R, Honda H, Sakae H, Hasegawa K, Horiguchi S, Kato H, Yamasaki O, Otsuka F.
    Mod Rheumatol Case Rep; 2021 Jul 04; 5(2):425-430. PubMed ID: 33821775
    [Abstract] [Full Text] [Related]

  • 79. Distinct changes to pancreatic volume rather than pancreatic autoantibody positivity: insights into immune checkpoint inhibitors induced diabetes mellitus.
    Wei HH, Lai YC, Lin G, Lin CW, Chang YC, Chang JW, Liou MJ, Chen IW.
    Diabetol Metab Syndr; 2024 Jan 23; 16(1):26. PubMed ID: 38254155
    [Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 27.